CCA Industries, Inc. Reports Results of Operations for the Quarter ended February 28, 2025
Rhea-AI Summary
CCA Industries (OTC: CAWW) has reported its Q1 2025 financial results, showing a significant turnaround with a net income of $13,731 compared to a loss of $245,410 in Q1 2024. EBITDA improved to $40,209 from a loss of $288,499 in the previous year.
Revenue decreased to $1.67 million from $2.13 million, attributed to a strategic decision to eliminate unprofitable sales in retail and Amazon direct-to-consumer channels. The company, which manufactures health and beauty aids including Plus White toothpaste, Nutra Nail treatments, and other branded products, expects to maintain profitability and plans to invest in brands with growth potential.
Basic and diluted earnings per share were $0.00, improving from -$0.03 in Q1 2024, with weighted average common shares outstanding remaining stable at 7,561,684.
Positive
- Achieved profitability with $13,731 net income vs $245,410 loss year-over-year
- EBITDA turned positive at $40,209 from -$288,499 previous year
- Strategic elimination of unprofitable sales improved bottom line
- Management expects continued profitability trend
Negative
- Revenue declined 22% to $1.67M from $2.13M year-over-year
- Earnings per share remained flat at $0.00
News Market Reaction 1 Alert
On the day this news was published, CAWW gained 11.25%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
The net income was
Further information, including the Unaudited Financial Statement for the first quarter ended February 28, 2025, the Audited Financial Statements for the year ended November 30, 2024, and the Quarterly Disclosure Statement filed with the OTC, may be found on the Company's investor web site: www.ccainvestor.com
CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus White" toothpaste and teeth whiteners, "Nutra Nail" nail care treatments, "Porcelana" skin care products, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, brands, "Hair Off" depilatory products, "Lobe Miracle" earlobe protection products and "Neutein" brain health supplements.
Statements contained in the news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which would cause actual results to differ materially, from estimated results. No assurance can be given that the results in any forward-looking statement will be achieved, and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.
CCA INDUSTRIES, INC. Financial Results (Unaudited) | |||
For the three months ended | |||
February 28, 2025 | February 29, 2024 | ||
Revenues | $ 1,665,946 | $ 2,134,581 | |
Net Income (Loss) | $ 13,731 | $ (245,410) | |
Income (Losses) Per Share: | |||
Basic | $ 0.00 | $ (0.03) | |
Diluted | $ 0.00 | $ (0.03) | |
Weighted Average Common Shares Outstanding: | |||
Basic | 7,561,684 | 7,561,684 | |
Diluted | 7,561,684 | 7,561,684 | |
EBITDA * | $ 40,209 | $ (288,499) | |
* Earnings before interest, taxes, depreciation and amortization | |||
Reconciliation of net income (loss) to EBITDA: | |||
Net Income | $ 13,731 | $ (245,410) | |
Provision for income taxes | (4,054) | (73,520) | |
Interest expense | 29,804 | 28,951 | |
Depreciation and Amortization | 728 | 1,480 | |
EBITDA | $ 40,209 | $ (288,499) | |
View original content:https://www.prnewswire.com/news-releases/cca-industries-inc-reports-results-of-operations-for-the-quarter-ended-february-28-2025-302429654.html
SOURCE CCA Industries, Inc.